| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |